Alternative Healing Goes High Tech: RightSmile and BG Medical Technologies Merge to Further Transform the Medical Cannabis Market
BOCA RATON, Fla. , Dec. 7, 2011 /PRNewswire/ — RightSmile, Inc. (OTC:RIGH) is pleased to announce the details of its pending Reverse Merger, to be completed later this month with BG Medical Technologies, Inc., an industry leader in medical cannabis laboratory analysis, and developer of popular medical cannabis website www.BudGenius.com.
BudGenius.com currently services the medical cannabis market utilizing a proprietary software engine that assists in predicting the medicinal effects of cannabis strains through a combination of laboratory chromatography analysis and patient response data received through its social media portal. Research results are displayed upon on the BudGenius.com website, and also within participating cannabis dispensaries, to assist patients in selecting cannabis strains that address their intended medical needs.
“We find this merger of science and social media to be quite remarkable,” stated CEO Angel Stanz . “Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson’s disease, Alzheimer’s, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies.”
BudGenius entered the medical cannabis industry as a pioneer in medical marijuana testing by providing the first online laboratory-tested strain database for patient and medical professionals. BudGenius continues to deliver industry-leading services, and maintains the largest online photographic database of tested cannabis medicine worldwide, obtained from over 230 independent sources within California . BudGenius.com is the most visited online portal for cannabis testing services.
“This [merger with RightSmile] provides BudGenius and BG Medical Technologies the resources to develop new levels of patient care for alternative medical treatments,” explains Mr. Stanz. “In 2012, BG Medical will continue our innovations by introducing support tools for medical care professionals, additional business tools for dispensaries, and interactive educational media content for patients. These features will be HIPAA-compliant, where applicable, and mobile app-enabled for patient convenience. ”
The breakthrough services BudGenius currently provides are powered by the combination of science, social media, and software development. Every cannabis plant represents a unique set of therapeutic characteristics based upon its genetics and growing environment. Each harvest is analyzed to determine its chemical composition and its safety for consumption. Patients receiving BudGenius tested medicine report on the efficacy of the experienced effects by utilizing the BudGenius.com social portal. These experiences are then mapped to the unique chemical ratios comprising the patient’s cannabis strain. This produces a loosely controlled scientific trial of thousands of patients, all contributing data in real-time to BG Medical’s server cloud. This information is then processed to extrapolate an ailment rating system for newly analyzed strains.
“We find this merger of science and social media to be quite remarkable,” continues Mr. Stanz. “Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson’s disease, Alzheimer’s, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies.”
BudGenius derives its revenue through cannabis analysis services. New growth will include targeted advertising services, physician support systems, medicinal administration solutions, and software licensing. Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this [$x million market] demand through territory expansion and appropriate acquisitions.
About BG Medical Technologies, Inc.
BG Medical Technologies is a life sciences solution developer for alternative medical treatments headquartered in California . BG Medical Technologies owns and operates BudGenius.com, a social web laboratory providing medical cannabis safety and treatment analysis.
Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this demand through territory expansion and its cloud-based architecture for supporting multiple licensed laboratory locations. New areas of growth include Internet advertising revenue, physician support software, and diagnostic support tools.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. In particular, management’s expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.